Published in J Clin Microbiol on July 01, 1991
Current methods of laboratory diagnosis of Chlamydia trachomatis infections. Clin Microbiol Rev (1997) 4.37
Diagnosis of Chlamydia trachomatis endocervical infections by a commercial polymerase chain reaction assay. J Clin Microbiol (1993) 3.82
Direct detection and genotyping of Chlamydia trachomatis in cervical scrapes by using polymerase chain reaction and restriction fragment length polymorphism analysis. J Clin Microbiol (1993) 2.59
Nucleotide sequence of the variable domains within the major outer membrane protein gene from serovariants of Chlamydia trachomatis. Infect Immun (1993) 2.15
Isolates of Chlamydia trachomatis that occupy nonfusogenic inclusions lack IncA, a protein localized to the inclusion membrane. Infect Immun (2000) 1.78
Genome sequencing of recent clinical Chlamydia trachomatis strains identifies loci associated with tissue tropism and regions of apparent recombination. Infect Immun (2010) 1.71
Comparison of two panels of monoclonal antibodies for determination of Chlamydia trachomatis serovars. J Clin Microbiol (1994) 1.48
Identification of concomitant infection with Chlamydia trachomatis IncA-negative mutant and wild-type strains by genomic, transcriptional, and biological characterizations. Infect Immun (2008) 1.48
Lateral gene transfer in vitro in the intracellular pathogen Chlamydia trachomatis. J Bacteriol (2006) 1.34
Evidence for naturally occurring recombination in the gene encoding the major outer membrane protein of lymphogranuloma venereum isolates of Chlamydia trachomatis. Infect Immun (1994) 1.27
The major outer membrane protein of a single Chlamydia trachomatis serovar can possess more than one serovar-specific epitope. Infect Immun (1996) 1.18
Susceptibility of Chlamydia trachomatis to chlorhexidine gluconate gel. Antimicrob Agents Chemother (1998) 1.16
Expression, processing, and localization of PmpD of Chlamydia trachomatis Serovar L2 during the chlamydial developmental cycle. PLoS One (2007) 1.06
Identification of individual genotypes of Chlamydia trachomatis from experimentally mixed serovars and mixed infections among trachoma patients. J Clin Microbiol (1994) 1.03
Genotyping of Chlamydia trachomatis serovars derived from heterosexual partners and a detailed genomic analysis of serovar F. Genitourin Med (1995) 1.03
Chlamydia trachomatis major outer membrane protein variants escape neutralization by both monoclonal antibodies and human immune sera. Infect Immun (1997) 1.01
Development of secondary inclusions in cells infected by Chlamydia trachomatis. Infect Immun (2005) 0.97
Genomic and phenotypic characterization of in vitro-generated Chlamydia trachomatis recombinants. BMC Microbiol (2013) 0.95
Analysis of pmpD expression and PmpD post-translational processing during the life cycle of Chlamydia trachomatis serovars A, D, and L2. PLoS One (2009) 0.93
Susceptibilities of Chlamydia trachomatis isolates causing uncomplicated female genital tract infections and pelvic inflammatory disease. Antimicrob Agents Chemother (1995) 0.93
Chlamydia trachomatis genovar distribution in clinical urogenital specimens from Tunisian patients: high prevalence of C. trachomatis genovar E and mixed infections. BMC Infect Dis (2012) 0.91
Evaluation of WLBU2 peptide and 3-O-octyl-sn-glycerol lipid as active ingredients for a topical microbicide formulation targeting Chlamydia trachomatis. Antimicrob Agents Chemother (2009) 0.90
Culture-independent sequence analysis of Chlamydia trachomatis in urogenital specimens identifies regions of recombination and in-patient sequence mutations. Microbiology (2013) 0.89
Genotyping of Chlamydia trachomatis by microsphere suspension array. J Clin Microbiol (2008) 0.81
Chlamydia trachomatis laboratory strains versus recent clinical isolates: implications for routine microbicide testing. Antimicrob Agents Chemother (2009) 0.79
Emancipating Chlamydia: Advances in the Genetic Manipulation of a Recalcitrant Intracellular Pathogen. Microbiol Mol Biol Rev (2016) 0.79
Susceptibility of Chlamydia trachomatis to excipients commonly used in topical microbicide formulations. Antimicrob Agents Chemother (2004) 0.78
Purification of Chlamydia trachomatis strains in mixed infection by monoclonal antibody neutralization. J Clin Microbiol (1994) 0.75
Derivation of specific antibody-producing tissue culture and tumor lines by cell fusion. Eur J Immunol (1976) 30.70
Monoclonal antibodies to Chlamydia trachomatis: antibody specificities and antigen characterization. J Immunol (1982) 8.61
Nucleotide and deduced amino acid sequences for the four variable domains of the major outer membrane proteins of the 15 Chlamydia trachomatis serovars. Infect Immun (1989) 5.75
Protective monoclonal antibodies recognize epitopes located on the major outer membrane protein of Chlamydia trachomatis. J Immunol (1987) 5.64
Immunotyping of Chlamydia trachomatis with monoclonal antibodies. J Infect Dis (1985) 5.29
Microtest procedure for isolation of Chlamydia trachomatis. J Clin Microbiol (1981) 4.14
Purification on renografin density gradients of Chlamydia trachomatis grown in the yolk sac of eggs. Appl Microbiol (1974) 3.64
Sensitivity of immunofluorescence with monoclonal antibodies for detection of Chlamydia trachomatis inclusions in cell culture. J Clin Microbiol (1982) 3.64
A simplified method for immunological typing of trachoma-inclusion conjunctivitis-lymphogranuloma venereum organisms. Infect Immun (1973) 2.93
Immunotypes of Chlamydia trachomatis isolates in Seattle, Washington. Infect Immun (1983) 2.76
Serovar distribution of urogenital Chlamydia trachomatis strains in The Netherlands. Genitourin Med (1988) 2.07
Serovar determination of Chlamydia trachomatis isolates by using type-specific monoclonal antibodies. J Clin Microbiol (1986) 2.06
CLASSIFICATION OF TRACHOMA VIRUS STRAINS BY PROTECTION OF MICE FROM TOXIC DEATH. J Immunol (1963) 1.83
Rapid immunotyping of Chlamydia trachomatis with monoclonal antibodies in a solid-phase enzyme immunoassay. J Clin Microbiol (1985) 1.79
Correlation of infecting serovar and local inflammation in genital chlamydial infections. J Infect Dis (1989) 1.65
Detection of multiple serovars of Chlamydia trachomatis in genital infections. J Infect Dis (1985) 1.61
Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med (1996) 11.91
Diagnosis of coliform infection in acutely dysuric women. N Engl J Med (1982) 8.75
Nosocomial acquisition of Clostridium difficile infection. N Engl J Med (1989) 7.72
Diagnosis of Chlamydia trachomatis genitourinary infection in women by ligase chain reaction assay of urine. Lancet (1995) 7.46
Causes of the acute urethral syndrome in women. N Engl J Med (1980) 6.91
Campylobacter cinaedi (sp. nov.) and Campylobacter fennelliae (sp. nov.): two new Campylobacter species associated with enteric disease in homosexual men. J Infect Dis (1985) 6.32
Culture-independent diagnosis of Chlamydia trachomatis using monoclonal antibodies. N Engl J Med (1984) 6.08
Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA). Clin Infect Dis (1999) 5.99
Detection of Chlamydia trachomatis inclusions in Mccoy cell cultures with fluorescein-conjugated monoclonal antibodies. J Clin Microbiol (1983) 5.70
Diagnosis and treatment of uncomplicated urinary tract infection. Infect Dis Clin North Am (1997) 5.27
Ligase chain reaction to detect Chlamydia trachomatis infection of the cervix. J Clin Microbiol (1994) 5.15
Criteria for selective screening for Chlamydia trachomatis infection in women attending family planning clinics. JAMA (1986) 4.93
Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women. JAMA (1999) 4.69
A prospective study of risk factors for symptomatic urinary tract infection in young women. N Engl J Med (1996) 4.69
Transmission of infection by gastrointestinal endoscopy and bronchoscopy. Ann Intern Med (1993) 4.54
Diagnosis of Chlamydia trachomatis urethritis in men by polymerase chain reaction assay of first-catch urine. J Clin Microbiol (1993) 4.50
Characterization of Campylobacter-like organisms isolated from homosexual men. J Infect Dis (1984) 4.23
Relationships of vaginal Lactobacillus species, cervical Chlamydia trachomatis, and bacterial vaginosis to preterm birth. Obstet Gynecol (1988) 4.23
Evaluation of new anti-infective drugs for the treatment of urinary tract infection. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis (1992) 4.20
Microtest procedure for isolation of Chlamydia trachomatis. J Clin Microbiol (1981) 4.14
Urinary tract infections in women: diagnosis and treatment. Ann Intern Med (1989) 3.97
Diagnosis of Chlamydia trachomatis urethral infection in symptomatic and asymptomatic men by testing first-void urine in a ligase chain reaction assay. J Infect Dis (1994) 3.93
Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections. Ann Intern Med (2001) 3.92
Lack of circumcision increases the risk of urinary tract infection in young men. JAMA (1992) 3.90
Evidence for long-term cervical persistence of Chlamydia trachomatis by omp1 genotyping. J Infect Dis (2000) 3.86
Diagnosis of Chlamydia trachomatis endocervical infections by a commercial polymerase chain reaction assay. J Clin Microbiol (1993) 3.82
A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med (1993) 3.18
Diagnosis of Chlamydia trachomatis infections by direct immunofluorescence staining of genital secretions. A multicenter trial. Ann Intern Med (1984) 3.15
The polymicrobial origin of intestinal infections in homosexual men. N Engl J Med (1983) 3.12
Chlamydia trachomatis proctitis. N Engl J Med (1981) 3.02
Effect of treatment regimens for Neisseria gonorrhoeae on simultaneous infection with Chlamydia trachomatis. N Engl J Med (1984) 2.89
Patient-initiated treatment of uncomplicated recurrent urinary tract infections in young women. Ann Intern Med (2001) 2.83
A prospective study of asymptomatic bacteriuria in sexually active young women. N Engl J Med (2000) 2.81
Nonculture tests for genital tract chlamydial infection. What does the package insert mean, and will it mean the same thing tomorrow? Sex Transm Dis (1992) 2.80
Randomized comparative trial and cost analysis of 3-day antimicrobial regimens for treatment of acute cystitis in women. JAMA (1995) 2.75
Sexually transmitted diseases in victims of rape. N Engl J Med (1990) 2.74
Comparison of Chlamydia trachomatis serovars causing rectal and cervical infections. J Infect Dis (1987) 2.66
Infections with Campylobacter jejuni and Campylobacter-like organisms in homosexual men. Ann Intern Med (1984) 2.65
Influence of the normal menstrual cycle on vaginal tissue, discharge, and microflora. Clin Infect Dis (2000) 2.64
Long-term eradication of Chlamydia trachomatis genital infection after antimicrobial therapy. Evidence against persistent infection. JAMA (1993) 2.63
Risk factors for recurrent urinary tract infection in young women. J Infect Dis (2000) 2.48
Chlamydia trachomatis urethral infections in men. Prevalence, risk factors, and clinical manifestations. Ann Intern Med (1984) 2.44
Use of HL cells for improved isolation and passage of Chlamydia pneumoniae. J Clin Microbiol (1990) 2.36
Prevalence and characterization of hippurate-negative Campylobacter jejuni in King County, Washington. J Clin Microbiol (1987) 2.33
Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in women: a nationwide analysis. Clin Infect Dis (2001) 2.24
Use of sequential enzyme immunoassay and direct fluorescent antibody tests for detection of Chlamydia trachomatis infections in women. J Clin Microbiol (1990) 2.22
Measurement of pyuria and its relation to bacteriuria. Am J Med (1983) 2.19
Risk factors for Clostridium difficile carriage and C. difficile-associated diarrhea in a cohort of hospitalized patients. J Infect Dis (1990) 2.17
Nucleotide sequence of the variable domains within the major outer membrane protein gene from serovariants of Chlamydia trachomatis. Infect Immun (1993) 2.15
Nosocomial multiply resistant Klebsiella pneumoniae: epidemiology of an outbreak of apparent index case origin. Antimicrob Agents Chemother (1979) 2.13
Chlamydial infections. What should we do while waiting for a diagnostic test? West J Med (1981) 2.11
Staining characteristics of six commercially available monoclonal immunofluorescence reagents for direct diagnosis of Chlamydia trachomatis infections. J Clin Microbiol (1988) 2.10
Campylobacter cinaedi is normal intestinal flora in hamsters. J Clin Microbiol (1989) 2.09
Serovar distribution of urogenital Chlamydia trachomatis strains in The Netherlands. Genitourin Med (1988) 2.07
Bacteremia caused by Campylobacter-like organisms in two male homosexuals. Ann Intern Med (1984) 2.07
Selective screening for Chlamydia trachomatis infection in a primary care population of women. Am J Epidemiol (1993) 2.06
Evaluation of nucleic acid amplification tests as reference tests for Chlamydia trachomatis infections in asymptomatic men. J Clin Microbiol (2000) 2.02
Monoclonal antibodies for diagnosis of infectious diseases in humans. Science (1983) 2.02
Infection due to Corynebacterium species in marrow transplant patients. Ann Intern Med (1979) 1.94
Aerobactin and other virulence factor genes among strains of Escherichia coli causing urosepsis: association with patient characteristics. Infect Immun (1988) 1.93
Inverse association of H2O2-producing lactobacilli and vaginal Escherichia coli colonization in women with recurrent urinary tract infections. J Infect Dis (1998) 1.92
Epidemics of nosocomial urinary tract infection caused by multiply resistant gram-negative bacilli: epidemiology and control. J Infect Dis (1976) 1.92
Sexually transmitted diseases in females in a juvenile detention center. Sex Transm Dis (1985) 1.91
Pseudoepidemics in hospital. Lancet (1977) 1.89
In vitro susceptibilities of Campylobacter-like organisms to twenty antimicrobial agents. Antimicrob Agents Chemother (1985) 1.88
Endometrial histopathology in patients with culture-proved upper genital tract infection and laparoscopically diagnosed acute salpingitis. Am J Surg Pathol (1990) 1.88
Chromosomal restriction fragment length polymorphism analysis of Escherichia coli strains causing recurrent urinary tract infections in young women. J Infect Dis (1995) 1.87
Prevalence of Mycoplasma genitalium determined by DNA probe in men with urethritis. Lancet (1988) 1.86
Isolation of "Campylobacter hyointestinalis" from a human. J Clin Microbiol (1986) 1.85
"Campylobacter cinaedi" bacteremia: case report and laboratory findings. J Clin Microbiol (1987) 1.83
Use of a urine enzyme immunoassay as a diagnostic tool for Chlamydia trachomatis urethritis in men. J Clin Microbiol (1991) 1.81
Rapid immunotyping of Chlamydia trachomatis with monoclonal antibodies in a solid-phase enzyme immunoassay. J Clin Microbiol (1985) 1.79
Isolates of Chlamydia trachomatis that occupy nonfusogenic inclusions lack IncA, a protein localized to the inclusion membrane. Infect Immun (2000) 1.78
Establishing the cause of genitourinary symptoms in women in a family practice. Comparison of clinical examination and comprehensive microbiology. JAMA (1984) 1.77
Chlamydia trachomatis IncA is localized to the inclusion membrane and is recognized by antisera from infected humans and primates. Infect Immun (1998) 1.75
Association of carboxylesterase B electrophoretic pattern with presence and expression of urovirulence factor determinants and antimicrobial resistance among strains of Escherichia coli that cause urosepsis. Infect Immun (1991) 1.73
Etiology of cervical inflammation. Am J Obstet Gynecol (1986) 1.72
Intestinal spirochetosis in homosexual men. Am J Med (1987) 1.72
Treatment of the acute urethral syndrome. N Engl J Med (1981) 1.71
Escherichia coli bacteriuria and contraceptive method. JAMA (1991) 1.71
Cytologic manifestations of cervical and vaginal infections. I. Epithelial and inflammatory cellular changes. JAMA (1985) 1.66
Urinary-tract infection in sexually active homosexual men. Lancet (1986) 1.66
Detection of Mycoplasma genitalium in women with laparoscopically diagnosed acute salpingitis. Sex Transm Infect (2005) 1.65
Adequacy of fellowship training: results of a survey of recently graduated fellows. Clin Infect Dis (2001) 1.63
O, K, and H antigens predict virulence factors, carboxylesterase B pattern, antimicrobial resistance, and host compromise among Escherichia coli strains causing urosepsis. J Infect Dis (1994) 1.62
Horizontal transfer of tetracycline resistance among Chlamydia spp. in vitro. Antimicrob Agents Chemother (2009) 1.62
Antimicrobial prophylaxis of recurrent urinary tract infections: a double-blind, placebo-controlled trial. Ann Intern Med (1980) 1.61
Detection of multiple serovars of Chlamydia trachomatis in genital infections. J Infect Dis (1985) 1.61
Community-based urine screening for Chlamydia trachomatis with a ligase chain reaction assay. Ann Intern Med (1997) 1.60
Successive bacteremias with "Campylobacter cinaedi" and "Campylobacter fennelliae" in a bisexual male. J Clin Microbiol (1987) 1.60
Indwelling arterial catheters as a source of nosocomial bacteremia. An outbreak caused by Flavobacterium Species. N Engl J Med (1975) 1.59
Histopathology of endocervical infection caused by Chlamydia trachomatis, herpes simplex virus, Trichomonas vaginalis, and Neisseria gonorrhoeae. Hum Pathol (1990) 1.58
Urovirulence determinants in Escherichia coli isolates causing first-episode and recurrent cystitis in women. J Infect Dis (1991) 1.57
Persistence of Mycoplasma hominis after therapy: importance of tetracycline resistance and of coexisting vaginal flora. Sex Transm Dis (1984) 1.53
Recurrent urinary tract infections in postmenopausal women. Clin Infect Dis (2000) 1.52
Transmission of Histoplasma capsulatum by organ transplantation. N Engl J Med (2000) 1.49
Toward control of sexually transmitted chlamydial infections. Ann Intern Med (1993) 1.48
Asymptomatic Chlamydia trachomatis urethritis in men. Sex Transm Dis (1986) 1.47
Seroprevalence to Bartonella quintana among patients at a community clinic in downtown Seattle. J Infect Dis (1996) 1.46